386 related articles for article (PubMed ID: 20015050)
21. Generation of engineered recombinant hepatocyte growth factor cleaved and activated by Genenase I.
Hayata D; Fukuta K; Matsumoto K; Adachi E; Hanada K; Adachi K; Nakamura T
J Biotechnol; 2008 Feb; 133(4):478-85. PubMed ID: 18178280
[TBL] [Abstract][Full Text] [Related]
22. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte growth factor activator (HGFA): a serine protease that links tissue injury to activation of hepatocyte growth factor.
Miyazawa K
FEBS J; 2010 May; 277(10):2208-14. PubMed ID: 20402766
[TBL] [Abstract][Full Text] [Related]
24. Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase.
Kilpatrick LM; Harris RL; Owen KA; Bass R; Ghorayeb C; Bar-Or A; Ellis V
Blood; 2006 Oct; 108(8):2616-23. PubMed ID: 16794252
[TBL] [Abstract][Full Text] [Related]
25. Purification and characterization of hepatocyte growth factor (HGF)-converting enzyme: activation of pro-HGF.
Mizuno K; Tanoue Y; Okano I; Harano T; Takada K; Nakamura T
Biochem Biophys Res Commun; 1994 Feb; 198(3):1161-9. PubMed ID: 8117273
[TBL] [Abstract][Full Text] [Related]
26. Geldanamycins exquisitely inhibit HGF/SF-mediated tumor cell invasion.
Xie Q; Gao CF; Shinomiya N; Sausville E; Hay R; Gustafson M; Shen Y; Wenkert D; Vande Woude GF
Oncogene; 2005 May; 24(23):3697-707. PubMed ID: 15782129
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.
Shimizu M; Hara A; Okuno M; Matsuno H; Okada K; Ueshima S; Matsuo O; Niwa M; Akita K; Yamada Y; Yoshimi N; Uematsu T; Kojima S; Friedman SL; Moriwaki H; Mori H
Hepatology; 2001 Mar; 33(3):569-76. PubMed ID: 11230736
[TBL] [Abstract][Full Text] [Related]
28. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.
Kim KR; Yoshizaki T; Miyamori H; Hasegawa K; Horikawa T; Furukawa M; Harada S; Seiki M; Sato H
Oncogene; 2000 Mar; 19(14):1764-71. PubMed ID: 10777210
[TBL] [Abstract][Full Text] [Related]
29. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease.
Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N
J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801
[TBL] [Abstract][Full Text] [Related]
30. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
31. Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist.
Kirchhofer D; Lipari MT; Santell L; Billeci KL; Maun HR; Sandoval WN; Moran P; Ridgway J; Eigenbrot C; Lazarus RA
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5306-11. PubMed ID: 17372204
[TBL] [Abstract][Full Text] [Related]
32. Matriptase/epithin participates in mammary epithelial cell growth and morphogenesis through HGF activation.
Lee SL; Huang PY; Roller P; Cho EG; Park D; Dickson RB
Mech Dev; 2010; 127(1-2):82-95. PubMed ID: 19853659
[TBL] [Abstract][Full Text] [Related]
33. Use of IHC and newly designed matriptase inhibitors to elucidate the role of matriptase in pancreatic ductal adenocarcinoma.
Uhland K; Siphos B; Arkona C; Schuster M; Petri B; Steinmetzer P; Mueller F; Schweinitz A; Steinmetzer T; Van De Locht A
Int J Oncol; 2009 Aug; 35(2):347-57. PubMed ID: 19578749
[TBL] [Abstract][Full Text] [Related]
34. Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans.
Okumura Y; Hayama M; Takahashi E; Fujiuchi M; Shimabukuro A; Yano M; Kido H
Biochem J; 2006 Dec; 400(3):551-61. PubMed ID: 16872279
[TBL] [Abstract][Full Text] [Related]
35. Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2.
Damalanka VC; Janetka JW
Future Med Chem; 2019 Apr; 11(7):743-769. PubMed ID: 30945556
[TBL] [Abstract][Full Text] [Related]
36. Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.
Franco FM; Jones DE; Harris PK; Han Z; Wildman SA; Jarvis CM; Janetka JW
Bioorg Med Chem; 2015 May; 23(10):2328-43. PubMed ID: 25882520
[TBL] [Abstract][Full Text] [Related]
37. Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion.
Tervonen TA; Belitškin D; Pant SM; Englund JI; Marques E; Ala-Hongisto H; Nevalaita L; Sihto H; Heikkilä P; Leidenius M; Hewitson K; Ramachandra M; Moilanen A; Joensuu H; Kovanen PE; Poso A; Klefström J
Oncogene; 2016 Apr; 35(14):1832-46. PubMed ID: 26165838
[TBL] [Abstract][Full Text] [Related]
38. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease.
Lee SL; Dickson RB; Lin CY
J Biol Chem; 2000 Nov; 275(47):36720-5. PubMed ID: 10962009
[TBL] [Abstract][Full Text] [Related]
39. Antithrombin regulates matriptase activity involved in plasmin generation, syndecan shedding, and HGF activation in keratinocytes.
Chen YW; Xu Z; Baksh AN; Wang JK; Chen CY; Swanson R; Olson ST; Kataoka H; Johnson MD; Lin CY
PLoS One; 2013; 8(5):e62826. PubMed ID: 23675430
[TBL] [Abstract][Full Text] [Related]
40. Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice.
Hsu YC; Huang HP; Yu IS; Su KY; Lin SR; Lin WC; Wu HL; Shi GY; Tao MH; Kao CH; Wu YM; Martin PE; Lin SY; Yang PC; Lin SW
Hepatology; 2012 Nov; 56(5):1913-23. PubMed ID: 22505209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
